The Substance Abuse and Mental Health Services Administration yesterday extended certain methadone take-home flexibilities for opioid treatment programs until one year after the end of the COVID-19 public health emergency, and said it is considering ways to make the flexibilities permanent. 

SAMHSA in 2020 allowed states to request a blanket exception to allow stable patients in an opioid treatment program to receive 28 days of take-home doses of their OUD medication, and other eligible patients to receive up to 14 days of take-home medication, which the agency said has enhanced and encouraged use of treatment services.
 

Related News Articles

Headline
April 30 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
The AHA yesterday launched the newest poster in its People Matter, Words Matter series, a collaborative effort with the National Center for PTSD to help…
Headline
The Department of Justice’s Civil Rights Division this week released guidance on how the Americans with Disabilities Act can protect individuals with opioid…
Headline
The Substance Abuse and Mental Health Services Administration yesterday released a toolkit to help health care providers and others prepare for the July 16…
Headline
While intentional drug overdoses have declined overall in the United States, they have increased among young people, the elderly and Black women, according to…
Headline
The departments of Labor, Health and Human Services, and the Treasury yesterday released their latest report to Congress on group health plan compliance…